Clinical Trial

Determining Cell- and Spatially-distinct Skeletal Muscle Transcriptional Aberrations in Insulin Resistance

Name: Determining Cell- and Spatially-distinct Skeletal Muscle Transcriptional Aberrations in Insulin Resistance — clinical trial record (NCT07516509)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: POINTS 2

Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this study is to find new signs or signals in muscle cells that can help us understand when the body isn't responding well to insulin (a condition called insulin resistance).

Protocol Amendment History 1 change

critical Recruitment opened 2026-08-13

Trial Details

NCT Number	NCT07516509
Lead Sponsor	AdventHealth Translational Research Institute Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions	Insulin Resistance
Enrollment	36 participants
Start Date	2026-06-11
Primary Completion	2028-12 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2026-08-12